Glycemic status and brain injury in older individuals: The age gene/environment susceptibility-Reykjavik study

Diabetes Care

Volumn 32, Issue 9, 2009, Pages 1608-1613

  Saczynski, Jane S ^a,b   Siggurdsson, Sigurdur ^c   Jonsson, Palmi V ^c,d   Eiriksdottir, Gudny ^c   Olafsdottir, Elin ^c   Kjartansson, Olafur ^c,d   Harris, Tamara B ^b   Van Buchem, Mark A ^e   Gudnason, Vilmundur ^c,d   Launer, Lenore J ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c ICELANDIC HEART ASSOCIATION   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

AGED; ARTICLE; BRAIN ATROPHY; BRAIN INFARCTION; BRAIN INJURY; BRAIN SIZE; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; GRAY MATTER; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; WHITE MATTER;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN INJURIES; CEREBRAL INFARCTION; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; SEX FACTORS;

EID: 69549121833     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-2300     Document Type: Article

References (24)

1. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787 (Pubitemid 34000780)
2. Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M. Type 2 diabetes in the young: the evolving epidemic: the International Diabetes Federation Consensus Workshop. Diabetes Care 2004;27:1798-1811 (Pubitemid 38857467)
3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053
4. Charlton J, Latinovic R, Gulliford MC. Explaining the decline in early mortality in men and women with type 2 diabetes: a population-based cohort study. Diabetes Care 2008;31:1761-1766
5. Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z, Bennett DA. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 2006;67:1960-1965 (Pubitemid 44967371)
6. Saczynski JS, Jonsdottir MK, Garcia ME, Jonsson PV, Peila R, Eiriksdottir G, Olafsdottir E, Harris TB, Gudnason V, Launer LJ. Cognitive impairment: an increasingly important complication of type 2 diabetes: the Age, Gene/Environment Susceptibility-Reykjavik Study. Am J Epidemiol 2008;168:1132-1139
7. Cersosimo E, DeFronzo R. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev 2006;22:423-436 (Pubitemid 44774046)
8. Starr JM, Wardlaw J, Ferguson K, MacLullich A, Deary IJ, Marshall I. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2003;74:70-76 (Pubitemid 36069039)
9. Guerci B, Bohme P, Kearney-Schwartz A, Zannad F, Drouin P. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatment in type 2 diabetes mellitus. Diabetes Metab 2001;27:436-447
10. Craft S, Stennis Watson G. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004;3:169-178 (Pubitemid 38229951)
11. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes 2002; 51:1256-1262
12. Harris TB, Launer LJ, Eiriksdottir G, Kjartansson O, Jonsson PV, Sigurdsson G, Thorgeirsson G, Aspelund T, Garcia ME, Cotch MF, Hoffman HJ, Gudnason V. Age, Gene/Environment Susceptibility-Reykjavik Study: multidisciplinary applied phenomics. Am J Epidemiol 2007; 165:1076-1087 (Pubitemid 46598837)
13. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GDO, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350:1387-1397 (Pubitemid 38419992)
14. Zijdenbos AF, Evans A. Automatic "pipeline" analysis of 3-D MRI data for clinical trials: application to multiple sclerosis. IEEE Trans Med Imaging 2002;21:1280-1292
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006;27(Suppl. 1): S5-S20
16. Department of Noncommunicable Disease Surveillance, World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva, World Health Organization, 1999
17. Luchsinger JA, Tang M-X, Stern Y, Shea S, Mayeux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001;154:635-641 (Pubitemid 32888781)
18. Sheikh J, Yesavage J: Geriatric Depression Scale (GDS): Recent Evidence and Development of a Shorter Version. New York, Hawthorne Press, 1986
19. Tiehuis AM, van der Graaf Y, Visseren FL, Vincken KL, Biessels GJ, Appelman APA, Kappelle LJ, Mali WPTM, SMART Study Group. Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease. Stroke 2008;39:1600-1603
20. Last D, Alsop DC, Abduljalil AM, Marquis RP, de Bazelaire C, Hu K, Cavallerano J, Novak V. Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 2007;30:1193-1199 (Pubitemid 46684647)
21. Williamson JD, Miller ME, Bryan RN, Lazar RM, Coker LH, Johnson J, Cukierman T, Horowitz KR, Murray A, Launer LJ. The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods.AmJ Cardiol 2007;99: S112-S122
22. Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. Diabetes Res Clin Pract 2000;50: 203-212
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12: 189-198
24. Kaplan E, Fein D, Morris R, Delis D. The WAIS-R as a Neuropsychological Instrument. San Antonio, TX, Psychological Corporation, 1991